Citadel Advisors’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-16,260
| Closed | -$48.4K | – | 15750 |
|
|
2023
Q3 | $48.4K | Sell |
16,260
-16,925
| -51% | -$39.4K | ﹤0.01% | 11789 |
|
|
2023
Q2 | $80.6K | Sell |
33,185
-61,261
| -65% | -$101K | ﹤0.01% | 11242 |
|
|
2023
Q1 | $161K | Buy |
+94,446
| New | +$214K | ﹤0.01% | 10527 |
|
|
2021
Q4 | – | Sell |
-1,286
| Closed | -$59K | – | 15278 |
|
|
2021
Q3 | $59K | Buy |
1,286
+754
| +142% | +$37K | ﹤0.01% | 13280 |
|
|
2021
Q2 | $32K | Buy |
532
+21
| +4% | +$1.48K | ﹤0.01% | 13472 |
|
|
2021
Q1 | $52K | Buy |
+511
| New | +$44K | ﹤0.01% | 12887 |
|
|
2019
Q4 | – | Sell |
-25
| Closed | -$5K | – | 9993 |
|
|
2019
Q3 | $5K | Buy |
25
+3
| +14% | +$719 | ﹤0.01% | 9072 |
|
|
2019
Q2 | $8K | Sell |
22
-6
| -21% | -$4.68K | ﹤0.01% | 9056 |
|
|
2019
Q1 | $36K | Buy |
+28
| New | +$45.4K | ﹤0.01% | 8948 |
|
|
2018
Q4 | – | Sell |
-20
| Closed | -$57K | – | 9985 |
|
|
2018
Q3 | $57K | Sell |
20
-2
| -9% | -$5.78K | ﹤0.01% | 8779 |
|
|
2018
Q2 | $71K | Buy |
22
+12
| +120% | +$40.5K | ﹤0.01% | 8363 |
|
|
2018
Q1 | $34K | Buy |
+10
| New | +$29.6K | ﹤0.01% | 8025 |
|
|
2017
Q4 | – | Sell |
-2
| Closed | -$8K | – | 8597 |
|
|
2017
Q3 | $8K | Buy |
2
+1
| +100% | +$5.14K | ﹤0.01% | 7446 |
|
|
2017
Q2 | $9K | Sell |
1
-1
| -50% | -$8.71K | ﹤0.01% | 7378 |
|
|
2017
Q1 | $15K | Buy |
+2
| New | +$13.8K | ﹤0.01% | 7317 |
|
|
2016
Q3 | – | Sell |
-1
| Closed | -$9K | – | 7944 |
|
|
2016
Q2 | $9K | Hold |
1
| – | – | ﹤0.01% | 6733 |
|
|
2016
Q1 | $16K | Hold |
1
| – | – | ﹤0.01% | 6536 |
|
|
2015
Q4 | $19K | Buy |
+1
| New | +$18.9K | ﹤0.01% | 7980 |
|
Citadel Advisors's TMBR Position: Q4 2023 in Review
Citadel Advisors sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q4 2023, closing a stake of 16,260 shares — an estimated $48.4K sold.
Citadel Advisors first reported a position in TMBR in Q4 2015 and held it in 18 quarters. The position peaked at $161K in Q1 2023. 0 funds tracked by Wall St. Rank hold TMBR as of Q4 2023.
- Citadel Advisors reported no remaining Timber Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Citadel Advisors sold 16,260 Timber Pharmaceuticals, Inc. shares in Q4 2023, an estimated $48.4K.
- Citadel Advisors first reported a position in Timber Pharmaceuticals, Inc. in Q4 2015 and held it in 18 quarters.
- Citadel Advisors's Timber Pharmaceuticals, Inc. position peaked at $161K in Q1 2023.
- 0 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q4 2023.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.